Release
📈 Stocks
Ascletis Pharma Presents Preclinical Data for ASC48 and ASC37 at ObesityWeek
(8 days ago)
Ascletis Pharma showcases new preclinical data for its obesity pipeline, including the oral GIPR agonist ASC48 and the long-acting triple peptide agonist…